BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21273288)

  • 1. Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster.
    Del Greco M F; Pattaro C; Luchner A; Pichler I; Winkler T; Hicks AA; Fuchsberger C; Franke A; Melville SA; Peters A; Wichmann HE; Schreiber S; Heid IM; Krawczak M; Minelli C; Wiedermann CJ; Pramstaller PP
    Hum Mol Genet; 2011 Apr; 20(8):1660-71. PubMed ID: 21273288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating atrial natriuretic peptide genetic association study identifies a novel gene cluster associated with stroke in whites.
    Pereira NL; Tosakulwong N; Scott CG; Jenkins GD; Prodduturi N; Chai Y; Olson TM; Rodeheffer RJ; Redfield MM; Weinshilboum RM; Burnett JC
    Circ Cardiovasc Genet; 2015 Feb; 8(1):141-9. PubMed ID: 25452597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of natriuretic peptide polymorphisms on diastolic and metabolic function in a populational cohort: insights from the STANISLAS cohort.
    Xhaard C; Rouget R; Vodovar N; Le Floch E; Dandine-Roulland C; Wagner S; Bacq-Daian D; Thuillier Q; Boivin JM; Branlant C; Deleuze JF; Behm-Ansmant I; Zannad F; Rossignol P; Girerd N
    ESC Heart Fail; 2022 Feb; 9(1):729-739. PubMed ID: 34734498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-Wide Association Study Implicates Atrial Natriuretic Peptide Rather Than B-Type Natriuretic Peptide in the Regulation of Blood Pressure in the General Population.
    Salo PP; Havulinna AS; Tukiainen T; Raitakari O; Lehtimäki T; Kähönen M; Kettunen J; Männikkö M; Eriksson JG; Jula A; Blankenberg S; Zeller T; Salomaa V; Kristiansson K; Perola M
    Circ Cardiovasc Genet; 2017 Dec; 10(6):e001713. PubMed ID: 29237677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain natriuretic peptide and insulin resistance in older adults.
    Kim F; Biggs ML; Kizer JR; Brutsaert EF; de Filippi C; Newman AB; Kronmal RA; Tracy RP; Gottdiener JS; Djoussé L; de Boer IH; Psaty BM; Siscovick DS; Mukamal KJ
    Diabet Med; 2017 Feb; 34(2):235-238. PubMed ID: 27101535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASA Status,
    Hahn M; Stamer UM; Luedi MM; Book M; Rieder HU; Stüber F
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome.
    Johansson Å; Eriksson N; Lindholm D; Varenhorst C; James S; Syvänen AC; Axelsson T; Siegbahn A; Barratt BJ; Becker RC; Himmelmann A; Katus HA; Steg PG; Storey RF; Wallentin L;
    Hum Mol Genet; 2016 Apr; 25(7):1447-56. PubMed ID: 26908625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
    Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
    Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Dissection of a Super Enhancer Controlling the
    Man JCK; van Duijvenboden K; Krijger PHL; Hooijkaas IB; van der Made I; de Gier-de Vries C; Wakker V; Creemers EE; de Laat W; Boukens BJ; Christoffels VM
    Circ Res; 2021 Jan; 128(1):115-129. PubMed ID: 33107387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum level of ubiquinol and NT-proBNP, a marker for chronic heart failure, in healthy elderly subjects.
    Onur S; Niklowitz P; Jacobs G; Lieb W; Menke T; Döring F
    Biofactors; 2015; 41(1):35-43. PubMed ID: 25728634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of the human B-type natriuretic peptide precursor (NPPB) gene to chromosome 1p36.
    Arden KC; Viars CS; Weiss S; Argentin S; Nemer M
    Genomics; 1995 Mar; 26(2):385-9. PubMed ID: 7601467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.
    Newton-Cheh C; Larson MG; Vasan RS; Levy D; Bloch KD; Surti A; Guiducci C; Kathiresan S; Benjamin EJ; Struck J; Morgenthaler NG; Bergmann A; Blankenberg S; Kee F; Nilsson P; Yin X; Peltonen L; Vartiainen E; Salomaa V; Hirschhorn JN; Melander O; Wang TJ
    Nat Genet; 2009 Mar; 41(3):348-53. PubMed ID: 19219041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of blood pressure regulatory genes in the Agtrap-Plod1 locus associated with a deletion in Clcn6.
    Klemens CA; Dissanayake LV; Levchenko V; Zietara A; Palygin O; Staruschenko A
    Physiol Rep; 2022 Aug; 10(15):e15417. PubMed ID: 35927940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes.
    Ellis KL; Newton-Cheh C; Wang TJ; Frampton CM; Doughty RN; Whalley GA; Ellis CJ; Skelton L; Davis N; Yandle TG; Troughton RW; Richards AM; Cameron VA
    J Mol Cell Cardiol; 2011 Apr; 50(4):695-701. PubMed ID: 21276798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.
    Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE
    Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort.
    Geelhoed B; Börschel CS; Niiranen T; Palosaari T; Havulinna AS; Fouodo CJK; Scheinhardt MO; Blankenberg S; Jousilahti P; Kuulasmaa K; Zeller T; Salomaa V; Schnabel RB
    Europace; 2020 Oct; 22(10):1463-1469. PubMed ID: 32830215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of N-terminal pro-B-type natriuretic peptide and cardiac index in multiple injured patients: a prospective cohort study.
    Kirchhoff C; Leidel BA; Kirchhoff S; Braunstein V; Bogner V; Kreimeier U; Mutschler W; Biberthaler P
    Crit Care; 2008; 12(5):R118. PubMed ID: 18789145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
    van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
    Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.